FARALLON CAPITAL MANAGEMENT, L.L.C.
Long book
$16.79B
Q1 2026
Positions
168
Top-10 weight
51%
concentration
Last quarter
-6.0%
SPY -4.4%
Turnover
37%
of book per quarter
Strategy in plain words
auto-generated from filingsFARALLON CAPITAL MANAGEMENT, L.L.C. is a diversified fundamental manager, running a $16.79B US long book across 168 positions.
The portfolio is concentrated: the top 10 names carry 51% of the portfolio. The portfolio is actively managed, with meaningful quarterly turnover. Current anchor positions: ELECTRONIC ARTS INC, REVOLUTION MEDICINES INC, AMAZON.COM INC, MICROSOFT CORP, AON PLC-CLASS A.
Over the last 8 quarters its long book ran on average 0.4pp per quarter behind the S&P 500, beating the index in 3 of 8 quarters. We rate its filings as signal-bearing: position changes reflect genuine views.
Implied long-book return vs S&P 500
methodology: positions priced quarterly, no shorts/options Fund long book S&P 500
Q1 2024
+0.5%
Q2 2024
+11.4%
Q3 2024
+0.5%
Q4 2024
-4.0%
Q1 2025
+8.4%
Q2 2025
+4.0%
Q3 2025
+7.9%
Q4 2025
-6.0%
Sector allocation
Healthcare 43%
Technology 23%
Financials 13%
Consumer discretionary 9%
Services media 4%
Industrials 3%
Other 3%
Materials 3%
Long book by quarter
What does FARALLON CAPITAL own?
Q1 2026 13F| Company | Sector | Shares | Value | % of book | Change |
|---|---|---|---|---|---|
| EA ELECTRONIC ARTS INC | Technology | 7.5M | $1.52B | 9.1% | +48.4% |
| RVMD REVOLUTION MEDICINES INC | Healthcare | 13.6M | $1.32B | 7.9% | -6.7% |
| AMZN AMAZON.COM INC | Consumer discretionary | 4.2M | $878.6M | 5.2% | -6.3% |
| MSFT MICROSOFT CORP | Technology | 2.3M | $868.0M | 5.2% | +5.9% |
| AON AON PLC-CLASS A | Financials | 2.5M | $811.0M | 4.8% | -5.7% |
| BBIO BRIDGEBIO PHARMA INC | Healthcare | 9.4M | $695.5M | 4.1% | +4.1% |
| PTGX PROTAGONIST THERAPEUTICS INC | Healthcare | 6.3M | $669.2M | 4.0% | +3.3% |
| NTRA NATERA INC | Healthcare | 3.2M | $641.4M | 3.8% | -18.1% |
| EXEL EXELIXIS INC | Healthcare | 13.1M | $562.3M | 3.3% | -16.5% |
| AVGO BROADCOM INC | Technology | 1.8M | $550.8M | 3.3% | +99.4% |
| UNH UNITEDHEALTH GROUP INC | Financials | 1.8M | $492.9M | 2.9% | +13.9% |
| SNPS SYNOPSYS INC | Technology | 1.2M | $481.0M | 2.9% | +21.4% |
| BSX BOSTON SCIENTIFIC CORP | Healthcare | 7.5M | $468.8M | 2.8% | +0.4% |
| TMO THERMO FISHER SCIENTIFIC INC | Other | 881.5K | $433.3M | 2.6% | +38.7% |
| KKR KKR & CO INC | Financials | 4.7M | $432.1M | 2.6% | +131.5% |
| LNTH LANTHEUS HOLDINGS INC | Materials | 5.6M | $423.5M | 2.5% | +2.9% |
| WAB WABTEC CORP | Industrials | 1.6M | $402.2M | 2.4% | -35.0% |
| SCHW SCHWAB (CHARLES) CORP | Financials | 4.0M | $371.8M | 2.2% | +18.4% |
| LQDA LIQUIDIA CORP | Healthcare | 8.7M | $326.7M | 1.9% | Held |
| CRNX CRINETICS PHARMACEUTICALS IN | Healthcare | 8.3M | $302.8M | 1.8% | +20.3% |
| GOOG ALPHABET INC-CL C | Technology | 996.2K | $285.8M | 1.7% | +26.6% |
| ROIV ROIVANT SCIENCES LTD | Healthcare | 9.7M | $268.0M | 1.6% | +26048.6% |
| V VISA INC-CLASS A SHARES | Services media | 840.7K | $254.1M | 1.5% | +20.8% |
| ARMK ARAMARK | Consumer discretionary | 6.1M | $248.7M | 1.5% | -34.4% |
| BEAM BEAM THERAPEUTICS INC | Healthcare | 10.1M | $241.5M | 1.4% | +0.7% |
| DIS WALT DISNEY CO/THE | Services media | 2.4M | $231.5M | 1.4% | -41.8% |
| MA MASTERCARD INC - A | Services media | 435.1K | $217.4M | 1.3% | +152.0% |
| MCK MCKESSON CORP | Consumer discretionary | 234.3K | $202.8M | 1.2% | -21.6% |
| AGIO AGIOS PHARMACEUTICALS INC | Healthcare | 5.7M | $192.3M | 1.1% | +10.2% |
| TNGX TANGO THERAPEUTICS INC | Healthcare | 9.1M | $190.3M | 1.1% | -30.3% |
| GRAL GRAIL INC | Healthcare | 3.3M | $168.2M | 1.0% | +38.9% |
| TYRA TYRA BIOSCIENCES INC | Healthcare | 3.6M | $137.1M | 0.8% | +73.3% |
| THC TENET HEALTHCARE CORP | Healthcare | 452.2K | $85.3M | 0.5% | +21.5% |
| CAH CARDINAL HEALTH INC | Consumer discretionary | 368.0K | $77.8M | 0.5% | -36.1% |
| PCVX VAXCYTE INC | Healthcare | 1.3M | $73.3M | 0.4% | +25120.0% |
| DNTH DIANTHUS THERAPEUTICS INC | Healthcare | 836.0K | $70.2M | 0.4% | New |
| BTSG BRIGHTSPRING HEALTH SERVICES | Healthcare | 1.6M | $68.9M | 0.4% | +7250.0% |
| TWST TWIST BIOSCIENCE CORP | Healthcare | 1.4M | $67.8M | 0.4% | +18562.1% |
| CGON CG ONCOLOGY INC | Healthcare | 674.0K | $45.6M | 0.3% | +8325.0% |
| AZN ASTRAZENECA PLC | Healthcare | 226.5K | $44.7M | 0.3% | New |
| MRK MERCK & CO. INC. | Healthcare | 361.0K | $43.4M | 0.3% | New |
| ACHC ACADIA HEALTHCARE CO INC | Healthcare | 1.7M | $40.6M | 0.2% | New |
| IMVT IMMUNOVANT INC | Healthcare | 1.5M | $38.4M | 0.2% | +12783.3% |
| ENTA ENANTA PHARMACEUTICALS INC | Healthcare | 2.9M | $36.3M | 0.2% | +3.6% |
| JNJ JOHNSON & JOHNSON | Healthcare | 148.0K | $36.2M | 0.2% | New |
| BBNX BETA BIONICS INC | Healthcare | 3.6M | $36.2M | 0.2% | -16.4% |
| ASMB ASSEMBLY BIOSCIENCES INC | Healthcare | 1.2M | $34.1M | 0.2% | Held |
| PCSC PERCEPTIVE CAPITAL SOLUTIONS | Healthcare | 2.3M | $24.7M | 0.1% | Held |
| RPRX ROYALTY PHARMA PLC- CL A | Healthcare | 493.0K | $23.6M | 0.1% | New |
| NERV MINERVA NEUROSCIENCES INC | Healthcare | 2.4M | $14.2M | 0.1% | Held |
13F filing history
| Period | Form | Filed | Entries | Reported value | Flags | Source |
|---|---|---|---|---|---|---|
| Q1 2026 | 13F-HR/ANEW HOLDINGS | Aug 14, 2026 | 1 | $1.52B | canonical | SEC ↗ |
| Q1 2026 | 13F-HR | May 15, 2026 | 172 | $17.54B | confidential canonical | SEC ↗ |
| Q4 2025 | 13F-HR/ANEW HOLDINGS | Aug 14, 2026 | 1 | $1.03B | canonical | SEC ↗ |
| Q4 2025 | 13F-HR/ANEW HOLDINGS | May 15, 2026 | 2 | $883.7M | canonical | SEC ↗ |
| Q4 2025 | 13F-HR | Feb 17, 2026 | 151 | $20.72B | confidential canonical | SEC ↗ |
| Q3 2025 | 13F-HR/ARESTATEMENT | Feb 17, 2026 | 144 | $24.43B | canonical | SEC ↗ |
| Q3 2025 | 13F-HR | Nov 14, 2025 | 144 | $24.43B | confidential | SEC ↗ |
| Q2 2025 | 13F-HR/ANEW HOLDINGS | Feb 17, 2026 | 1 | $140.2M | canonical | SEC ↗ |
| Q2 2025 | 13F-HR/ANEW HOLDINGS | Nov 14, 2025 | 3 | $482.8M | canonical | SEC ↗ |
| Q2 2025 | 13F-HR | Aug 14, 2025 | 141 | $23.18B | confidential canonical | SEC ↗ |
| Q1 2025 | 13F-HR/ANEW HOLDINGS | Feb 17, 2026 | 1 | $273.9M | canonical | SEC ↗ |
| Q1 2025 | 13F-HR/ANEW HOLDINGS | Nov 14, 2025 | 3 | $416.4M | canonical | SEC ↗ |
| Q1 2025 | 13F-HR/ANEW HOLDINGS | Aug 14, 2025 | 7 | $2.23B | canonical | SEC ↗ |
| Q1 2025 | 13F-HR | May 15, 2025 | 135 | $17.94B | confidential canonical | SEC ↗ |
| Q4 2024 | 13F-HR/ANEW HOLDINGS | Feb 17, 2026 | 1 | $84.9M | canonical | SEC ↗ |
| Q4 2024 | 13F-HR/ANEW HOLDINGS | Nov 14, 2025 | 2 | $349.2M | canonical | SEC ↗ |
| Q4 2024 | 13F-HR/ANEW HOLDINGS | Aug 14, 2025 | 6 | $2.31B | canonical | SEC ↗ |
| Q4 2024 | 13F-HR/ANEW HOLDINGS | May 15, 2025 | 4 | $333.0M | canonical | SEC ↗ |
| Q4 2024 | 13F-HR | Feb 14, 2025 | 138 | $19.72B | canonical | SEC ↗ |
| Q3 2024 | 13F-HR/ANEW HOLDINGS | Nov 14, 2025 | 1 | $144.8M | canonical | SEC ↗ |
| Q3 2024 | 13F-HR/ANEW HOLDINGS | Aug 14, 2025 | 6 | $1.45B | canonical | SEC ↗ |
| Q3 2024 | 13F-HR/ANEW HOLDINGS | May 15, 2025 | 3 | $215.9M | canonical | SEC ↗ |
| Q3 2024 | 13F-HR/ANEW HOLDINGS | Feb 14, 2025 | 2 | $544.4M | canonical | SEC ↗ |
| Q3 2024 | 13F-HR | Nov 14, 2024 | 153 | $20.44B | confidential canonical | SEC ↗ |
Similar funds
DIAMANT ASSET MANAGEMENT, INC. LILLY ENDOWMENT INCBROOKFIELD Corp /ON/GQG Partners LLCMITSUBISHI UFJ FINANCIAL GROUP INCNewport Trust Company, LLCVIKING GLOBAL INVESTORS LPPARNASSUS INVESTMENTS, LLC MASTERCARD FOUNDATION ASSET MANAGEMENT CORPPZENA INVESTMENT MANAGEMENT LLCCOATUE MANAGEMENT LLCWinslow Capital Management, LLC